Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

SION·NASDAQ

$36.70

-10%
HealthcareBiotechnology

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

At a Glance

Live Snapshot
Market Cap$1.66B
EPS-1.8800
P/E Ratio-19.52
Earnings Date08/10/2026

No Dividend Yield Data

SION has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

SION has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

SION has not reported any net dividends paid values in the available annual periods.

Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc. Dividend History

SION · NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

SION Dividend Payment History

SION · NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
sion

Sionna Therapeutics, Inc. Payout Ratio Analysis

SION · NASDAQ
Dividends Paid
0.00
2025
Net Income
-75.27M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.

Sustainability
At Risk

Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.